Gardner's syndrome in a 40-year-old woman: Successful treatment of locally aggressive desmoid tumors with cytotoxic chemotherapy

World Journal of Surgical Oncology

Volumn 4, Issue , 2006, Pages

  Bhama, Prabhat K ^a   Chugh, Rashmi ^a   Baker, Laurence H ^a   Doherty, Gerard M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOTOXIC AGENT; DOXORUBICIN; IFOSFAMIDE; IMATINIB; TAMOXIFEN;

ADULT; ARTICLE; BARIUM ENEMA; CASE REPORT; COLON RESECTION; DESMOID TUMOR; DISEASE ACTIVITY; DRUG ABSORPTION; DRUG RESPONSE; DRUG WITHDRAWAL; ENTEROCUTANEOUS FISTULA; FEMALE; GARDNER SYNDROME; HUMAN; JEJUNUM; NUTRITIONAL SUPPORT; REPEATED DRUG DOSE; SMALL INTESTINE OBSTRUCTION; SMALL INTESTINE RESECTION; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 33846009106     PISSN: None     EISSN: 14777819     Source Type: Journal    
DOI: 10.1186/1477-7819-4-96     Document Type: Article

References (13)

1. Clark SK, Phillips RKS: Desmoids in familial adenomatous polyposis. Br J Surg 1996, 83:1494-504.
2. Ballo MT, Zagars GK, Pollack A, Pisters PW, Pollack RA: Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy. J Clin Oncol 1999, 17:158-167.
3. Poritz LS, Blackstein M, Berk T, Gallinger S, McLeod RS, Cohen Z: Extended follow-up of patients treated with cytotoxic chemotherapy for intra-abdominal desmoid tumors. Dis Colon Rectum 2001, 44:1268-1273.
4. Clark SK, Neale KF, Landgrebe JC, Phillips RK: Desmoid tumors complicating familial adenomatous polyposis. Br J Surg 1999, 86:1185-1189.
5. Wilcken N, Tattersall MH: Endocrine therapy for desmoid tumors. Cancer 1991, 68:1384-1388.
6. Tonelli F, Ficari F, Valanzano R, Brandi ML: Treatment of desmoids and mesenteric fibromatosis in familial adenomatous polyposis with raloxifine. Tumori 2003, 89:391-396.
7. Bus PJ, Verspaget HW, van Krieken JH, de Roos A, Keizer HJ, Bemelman WA, Vasen HF, Lamers CB, Griffioen G: Treatment of mesenteric desmoid tumors with the anti-oestrogenic agent toremifene: case histories and an overview of the literature. Eur J Gastroenterol Hepatol 1999, 11:1179-1183.
8. Tsukada K, Church JM, Jagelman DG, Fazio VW, McGannon E, George CR, Schroeder T, Lavery I, Oakley J: Noncytotoxic drug therapy for intra-abdominal desmoid tumor in patients with familial adenomatous polyposis. Dis Colon Rectum 1992, 35:29-33.
9. Mace J, Sybil Biermann J, Sondak V, McGinn C, Hayes C, Thomas D, Baker L: Response of extraabdominal desmoid tumors to therapy with imatinib mesylate. Cancer 2002, 95:2373-2379.
10. Baker LH, Wathen K, Chugh R, Thomas D, Thall PF, Maki RG, Samuels BL, Meyers PA, Priebat DA, Benjamin RS: Activity of imatinib mesylate in desmoid tumors: Interim results of a Sarcoma Alliance for Research thru Collaboration (SARC) phase II trial (abstract). J Clin Oncol 2004, 22(14S):9013. [Abst]
11. Azzarelli A, Gronchi A, Bertulli R, Tesoro JD, Baratti D, Pennacchioli E, Dileo P, Rasponi A, Ferrari A, Pilotti S, Casali PG: Low-dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis. Cancer 2001, 92:1259-1264.
12. Lynch HT, Fitzgibbons R Jr, Chong S, Cavalieri J, Lynch J, Wallace F, Patel S: Use of doxorubicin and dacarbazine for the management of unresectable intra-abdominal desmoid tumors in Gardner's syndrome. Dis Colon Rectum 1994, 37:260-267.
13. Patel SR, Evans HL, Benjamin RS: Combination chemotherapy in adult desmoid tumors. Cancer 1993, 72:3244-3247.